Vagus Nerve Stimulator Market

DelveInsight’s ‘Vagus Nerve Stimulator (VNS)-Market Insights, Competitive Landscape and Market Forecast-2026’ report delivers an in-depth understanding of Vagus Nerve Stimulators, historical and forecasted patient pool as well as the Vagus Nerve Stimulator market trends in the United States, EU5 (Germany, Spain, Italy, France and United Kingdom) and Japan.


The Vagus Nerve Stimulator market report provides an overview of Vagus Nerve Stimulator, reasons to get a Vagus Nerve Stimulator, as well as its advantages and limitations. Additionally, the report provides insights on the market share of the individual VNS devices, current and forecasted VNS machines market size from 2018 to 2026, segmented by seven major markets. The report also covers the market drivers, market barriers and unmet medical needs to curate best of the opportunities and assesses underlying potential of the market.

Vagus Nerve Stimulator Overview

Vagus Nerve stimulation comprises of a device that helps in stimulating the vagus nerve using the electric impulses. The VNS devices can be used to treat neurological conditions such as epilepsy and depression. Stimulation of the vagus nerve sends across lower electrical pulses to the brain, by the help of a device that is similar to a pacemaker. However, the brain is not physically involved during the surgery and does not feel the pain in the low voltage electrical pulses. Vagus nerve stimulation (VNS) has become an established therapy for difficult-to-treat epilepsy since the past 2 decades.


Study Period: 2018–2026

Geography Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain and the United Kingdom)
  • Japan

List of Companies:

  • tVNS Technologies
  • Parasym Ltd.
  • ElectroCore Inc.
  • Micro Transponder
  • LivaNova PLC
  • Soterix Medical
  • NeuroSigma
  • ReShape Lifesciences (formerly known as EnterMedics)
  • NeuroPace

More companies in the report…

Vagus Nerve Stimulators- Competitive Analysis

This segment of the report provides a brief competitive analysis of Vagus Nerve Stimulators, to help understand the competition in the market. It gives a comparative understanding of the Vagus Nerve Stimulators based on parameters such product type and their application.

Vagus Nerve Stimulators: Market Analysis

This segment illustrates the market of Vagus Nerve Stimulator across 7MM and how the market is expected to rise in the study period (2018 to 2026), at a significant CAGR.


Vagus Nerve Stimulators: Market Segmentation


By Type

  • Invasive VNS devices
  • Non-invasive VNS devices


By Application

  • Depression
  • Epilepsy
  • Others

Vagus Nerve Stimulators: Market Drivers and Barriers

The report provides insights into the market driving factors and the barriers shaping the vagus nerve stimulator (VNS) Market.


Factors responsible for driving the vagus nerve stimulation market include growing incidence of neurological disorders, and rising resistance to drugs among depression and epilepsy patients. Healthcare providers are shifting from a medication based treatment approach to a vagus nerve stimulation devices. The development of non-invasive VNS devices is further expected to increase demand and boost market growth. However, the high cost of surgical implantation of VNS devices may act as a barrier to market growth.


The market of VNS devices is witnessing technological advancements with the introduction of new innovative products in the market. Various market players have come up with newer non-invasive devices that replace the need for implantable VNS devices.


  • The gammaCore device by electroCore Inc. is an FDA approved, hand held VNS device for treatment of pain associated with headaches and migraine in adults, which can be used in home settings. Recently in July 2020, the gammaCore Sapphire CV received FDA Emergency Use Authorization (EUA) for emergency use in to treat adult patients with known or suspected COVID-19 who are experiencing exacerbation of asthma-related dyspnea and reduced airflow, and for whom approved drug therapies are not tolerated or provide insufficient symptom relief.
  • In June 2020, Neuroceuticals has signed a business alliance with KAGA ELECTRONICS with the help of this alliance, the electrical trading company, KAGA ELECTRONICS, will use the national and international network and try to develop new and latest technologies and electrical components that help in the development of innovative medical devices to meet the needs and demands of patients.
  • MicroTransponder announced a USD 5.5 Million round of funding planned to be used to launch the neurostimulation technology to treat neurological conditions with its aired Vagus Nerve Stimulation, which is designed to help patients with tinnitus as well as stroke victims(Hochmair et al., 2020).

KOL- Views

To keep up with the market trends, we take KOLs and SME’s opinion working in Vagus nerve stimulator domain through primary research to fill the data gaps and validate our secondary research. Their opinion helps to understand and validate current and emerging therapies treatment patterns or Vagus nerve stimulator market trend. This will support the clients in making informed business decisions by identifying the overall scenario of the market and the unmet needs.

Scope of the Report

  • The report covers the descriptive overview of Vagus nerve stimulators, explaining the reasons for replacement, procedure, advantages, and limitations, etc.
  • Additionally, an all-inclusive account of the currently available Vagus nerve stimulator is provided, which will have an impact on the future market of Vagus nerve stimulators.
  • A detailed review of Vagus nerve stimulator market; historical and forecasted market size is included in the report, covering devices outreach in the 7MM.
  • The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Vagus nerve stimulator market.

Report Highlights

  • The report covers descriptive overview of the Vagus nerve stimulators, explaining its applications, working mechanism, etc.
  • The report provides an insight into the patient population eligible for Implantation of Cardiac monitors in the 7 MM, covering the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.
  • The report is a comprehensive account of marketed devices present in the Vagus nerve stimulator market.
  • The report also reviews the detailed global historical and forecasted Vagus nerve stimulator devices market including assessing the outreach in 7 MM.
  • The report helps in developing business strategies by understanding trends shaping and driving the global Vagus nerve stimulator market.

Vagus Nerve Stimulator Report Key Strengths

  • 6 Years Forecast
  • 7MM Coverage
  • Competitive Landscape
  • Patient Pool
  • Market Size

Vagus Nerve Stimulator Report Assessment

  • Marketed Product profiles
  • Key Products and Key Players
  • Market Drivers and Barriers
  • Market Forecast
  • KOL’S views
  • PEST Analysis

Key Questions

Market Insights:

  • What was the Vagus Nerve Stimulator market share (%) distribution in 2018 and how it will look like in 2026?
  • What will be the Vagus Nerve Stimulator total market Size as well as market Size by devices across the 7MM during the forecast period (2018–2026)?
  • What are the key findings pertaining to the market across 7MM and which country will have the largest Vagus Nerve Stimulator market Size during the forecast period (2018–2026)?
  • At what CAGR, the Vagus Nerve Stimulator market is expected to grow in 7MM during the forecast period (2018–2026)?
  • What will be the Vagus Nerve Stimulator market outlook across the 7MM during the forecast period (2018–2026)?
  • What will be the Vagus Nerve Stimulator market growth till 2026 and what will be the resultant market Size in the year 2026?
  • How will the market drivers, barriers and future opportunities affect the market dynamics and a subsequent analysis of the associated trends?


Competitive Landscape:

  • What are the current devices available in the Vagus nerve stimulator market?
  • What is the Vagus nerve stimulator available in the market, their product description, regulatory milestones, product development activities, research and development activities etc.?
  • How many key players are developing Vagus nerve stimulators?
  • What are the key collaborations (Industry–Industry), Mergers and acquisitions, licensing activities related to the Vagus nerve stimulators?
  • What are the key designations that have been granted for the current Vagus nerve stimulators?
  • What are the global historical and forecasted market of Vagus nerve stimulators?

 

Frequently Asked Questions

What is a Vagus Nerve Stimulator?

Vagus nerve stimulators are used for stimulation of the vagus nerve by the help of electrical impulses. A Vagus Nerve Stimulator that can be implanted has been approved by the FDA for both epilepsy and depression. 


Who are the leading companies in Vagus Nerve Stimulator Market Landscape?

The leading companies that are working in the Vagus Nerve Stimulator Market are tVNS Technologies, Parasym Ltd, Electrocore Inc., LivaNova, Soterix Medical, NeuroSigma, ReShape Lifesciences, NeuroPace, MicroTransponder Inc., SetPoint Medical Corp, Neuroceuticals and others.


How is Vagus Nerve Stimulator Market Segmented?

The Vagus Nerve Stimulator Market is segmented on the basis of Product Type, Channel Type and End User.


At what CAGR is the Vagus Nerve Stimulator Market expected to rise?

Vagus Nerve Stimulator Market Expected To Rise At A CAGR Of 12.8% By 2026.


Which country holds the major share for Vagus Nerve Stimulator Market?

The United States holds the largest market share for Vagus Nerve Stimulator Market in 2021.


What drivers are contributing to the growth of Vagus Nerve Stimulator Market?

Vagus Nerve Stimulator Market is witnessing growth due to the factors like Simplicity in Product Design, Affordability, Advantages over Conventional Systems and Favorable Reimbursements policies among others.


What is the Impact of Covid-19 on Vagus Nerve Stimulator Market?

The Vagus Nerve Stimulator Market had observed a positive shift in market revenues due to the Covid 19 in 2020

1. Key Insights

2. Executive Summary of Vagus Nerve Stimulator

3. Vagus Nerve Stimulators: Background and Overview

3.1. Introduction

3.2 The approach of the Vagus Nerve Stimulator

3.3 Major applications associated with Vagus Nerve Stimulation

3.4 Components of VNS therapy and their mechanism

3.5 Regulatory scenario of VNS stimulators

4. Company Profiles

4.1. tVNS Technologies

4.1.1 Company Overview

4.1.2 Product Portfolio

4.1.2.1 Product description

4.1.2.2 Regulatory Milestones

4.1.2.3 Research and Development

4.1.2.4 Product Development Activities

4.2. Parasym Ltd.

4.2.1. Company Overview

4.2.2 Product Portfolio

4.2.2.1 Product description

4.2.2.2 Regulatory Milestones

4.2.2.3 Research and Development

4.2.2.4 Product Development Activities

4.3. Electrocore Inc.

4.3.1. Company Overview

4.3.2 Product Portfolio

4.3.2.1 Product description

4.3.2.2 Regulatory Milestones

4.3.2.3 Research and Development

4.3.2.4 Product Development Activities

4.4. Micro Transponder

4.4.1.Company Overview

4.4.2 Product Portfolio

4.4.2.1 Product description

4.4.2.2 Regulatory Milestones

4.4.2.3 Research and Development

4.4.2.4 Product Development Activities

4.5 LivaNova PLC

4.5.1.Company Overview

4.5.2 Product Portfolio

4.5.2.1 Product description

4.5.2.2 Regulatory Milestones

4.5.2.3 Research and Development

4.5.2.4 Product Development Activities

4.6 Soterix Medical

4.6.1.Company Overview

4.6.2 Product Portfolio

4.6.2.1 Product description

4.6.2.2 Regulatory Milestones

4.6.2.3 Research and Development

4.6.2.4 Product Development Activities

4.7 NeuroSigma

4.7.1. Company Overview

4.7.2 Product Portfolio

4.7.2.1 Product description

4.7.2.2 Regulatory Milestones

4.7.2.3 Research and Development

4.7.2.4 Product Development Activities

4.8 ReShape Lifesciences (formerly known as EnterMedics)

4.8.1.Company Overview

4.8.2 Product Portfolio

4.8.2.1 Product description

4.8.2.2 Regulatory Milestones

4.8.2.3 Research and Development

4.8.2.4 Product Development Activities

4.9 NeuroPace

4.9.1.Company Overview

4.9.2. Product Portfolio

4.9.2.1 Product description

4.9.2.2 Regulatory Milestones

4.9.2.3 Research and Development

4.9.2.4 Product Development Activities

Products detail in the report…

5 Patient Testimony

6 Vagus Nerve Stimulation Devices: Competitive Analysis

 6.1.1. Vagus Nerve Stimulation: Market Analysis in the 7MM by type (2018–2026)

 6.1.2. Vagus Nerve Stimulation: Market Analysis in the 7MM by application (2018–2026)

 6.2.1. Vagus Nerve Stimulation: Market Analysis in the US by type (2018-2026)

 6.2.2. Vagus Nerve Stimulation: Market Analysis in the US by application (2018-2026)

6.3.1. Vagus Nerve Stimulation: Market Analysis in Germany by type (2018-2026)

 6.3.2. Vagus Nerve Stimulation: Market Analysis in Germany by application (2018-2026)

 6.4.1. Vagus Nerve Stimulation: Market Analysis in France by type (2018-2026)

 6.4.2. Vagus Nerve Stimulation: Market Analysis in France by application (2018-2026)

 6.5.1. Vagus Nerve Stimulation: Market Analysis in Italy by type (2018-2026)

 6.5.2. Vagus Nerve Stimulation: Market Analysis in Italy by application (2018-2026)

 6.6.1. Vagus Nerve Stimulation: Market Analysis in Spain by type (2018-2026)

 6.6.2. Vagus Nerve Stimulation: Market Analysis in Spain by application (2018-2026)

 6.7.1. Vagus Nerve Stimulation: Market Analysis in the UK by type (2018-2026)

 6.7.2. Vagus Nerve Stimulation: Market Analysis in the UK by application (2018-2026)

  6.8.1. Vagus Nerve Stimulation: Market Analysis in Japan by type (2018-2026)

 6.8.2. Vagus Nerve Stimulation: Market Analysis in Japan by application (2018-2026)

7 Assumptions and Rationale– Eligible Patient Population and Market Analysis for Vagus Nerve Stimulation Devices

8 Vagus Nerve Stimulator devices: Eligible Patient Population

8.1 Vagus Nerve Stimulation: Eligible Patient Population of DRE for VNS Device in the 7MM (2018–2026)

8.2  Vagus Nerve Stimulation: Eligible Patient Population of TRD for VNS Device in the 7MM (2018–2026)

8.3 Vagus Nerve Stimulation: Eligible Patient Population for VNS Device in the United States (2018–2026)

8.4  Vagus Nerve Stimulation: Eligible Patient Population for VNS Device in Germany (2018–2026)

8.5 Vagus Nerve Stimulation: Eligible Patient Population for VNS Device in France (2018–2026)

8.6 Vagus Nerve Stimulation: Eligible Patient Population for VNS Device in Italy (2018–2026)

8.7 Vagus Nerve Stimulation: Eligible Patient Population for VNS Device in Spain (2018–2026)

8.8 Vagus Nerve Stimulation: Eligible Patient Population for VNS Device in the UK (2018–2026)

8.9 Vagus Nerve Stimulation: Eligible Patient Population for VNS Device in Japan (2018–2026)

9 Vagus Nerve Stimulation Devices: Market Analysis

9.1. Vagus Nerve Stimulation: Market Analysis in the 7MM (2018–2026)

9.2. Vagus Nerve Stimulation: United States Market Analysis (2018–2026) 

9.3. Vagus Nerve Stimulation: Germany Market Analysis (2018–2026)                

9.4. Vagus Nerve Stimulation: France Market Analysis (2018–2026)          

9.5. Vagus Nerve Stimulation: Italy Market Analysis (2018–2026)              

9.6. Vagus Nerve Stimulation: Spain Market Analysis (2018–2026)      

9.7. Vagus Nerve Stimulation: United Kingdom Market Analysis (2018–2026)            

9.8. Vagus Nerve Stimulation: Japan Market Analysis (2018–2026)            

10. Market Drivers

11. Market Barriers

12. Industry Trends

13. KOL’s Views

14. Analyst Views

15. PEST Analysis

16. Appendix

16.1. Bibliography

16.2. Report Methodology

17. DelveInsight Capabilities

18. Disclaimer

19. About DelveInsight

List of Table

Table 1: Competitive Analysis

Table 2: Eligible Patient Population of DRE for VNS Device in the 7MM (2018–2026)

Table 3: Eligible Patient Population of TRD for VNS Device in the 7MM (2018–2026)

Table 4: Eligible Patient Population for VNS Device in the United States (2018–2026)

Table 5: Eligible Patient Population for VNS Device in Germany (2018–2026)

Table 6:Eligible Patient Population for VNS Device in France (2018–2026)

Table 7: Eligible Patient Population for VNS Device in Italy (2018–2026)

Table 8: Eligible Patient Population for VNS Device in Spain (2018–2026)

Table 9: Eligible Patient Population for VNS Device in the UK (2018–2026)

Table 10: Eligible Patient Population for VNS Device in Japan (2018–2026)

Table 11: Vagus Nerve Stimulation: Market Size in the 7MM (2018–2026)

Table 12: Vagus Nerve Stimulation: Market Size in the 7MM by type (2018–2026)

Table 13: Vagus Nerve Stimulation: Market Size in the 7MM by application (2018–2026)

Table 14: Vagus Nerve Stimulation: United States Market Size (2018–2026)

Table 15: Vagus Nerve Stimulation: Market Size in the US by type (2018-2026)

Table 16: Vagus Nerve Stimulation: Market Size in the US by application (2018-2026)

Table 17: Vagus Nerve Stimulation: Germany Market Size (2018–2026)

Table 18: Vagus Nerve Stimulation: Market Size in Germany by type (2018-2026)

Table 19: Vagus Nerve Stimulation: Market Size in Germany by application (2018-2026)

Table 20: Vagus Nerve Stimulation: France Market Size (2018–2026)

Table 21: Vagus Nerve Stimulation: Market Size in France by type (2018-2026)

Table 22: Vagus Nerve Stimulation: Market Size in France by application (2018-2026)

Table 23: Vagus Nerve Stimulation: Italy Market Size (2018–2026)

List of Figure

Figure 1: Presence of Vagus Nerve in body

Figure 2: Components of a vagus nerve stimulator

Figure 3: Comparison of Device Approval Processes in the United States and EU

Figure 4: Product Specifications of the NEMOS Transcutaneous Vagus Nerve Stimulator

Figure 5: Product Specifications of the VITOS Transcutaneous Vagus Nerve Stimulator

Figure 6: Product Specifications of the Parasym Vagus Nerve Stimulator

Figure 7: Product Specification of the gammaCore Sapphire

Figure 8: Product specification of the Symmetry Device

Figure 9: Product specification of the Vitaria Model 7103

Figure 10: Product specification of the Sentiva

Figure 11: Product specification of the AspireSR

Figure 12: Product specification of the Transcutaneous Neurostimulator

Figure 13: Product specification of the Monarch eTNS System

Figure 14: Product specification of the vBloc Maestro

Figure 15: Product specification of the NeuroPace RNS System

Figure 16: Product specification of the Vivistim System

Figure 17: Product specification of the SetPoint Medical System

Figure 18: Product specification of the Vagal Nerve Stimulation Catheter System

Figure 19: Analysis of Listed Products by Product Type

Figure 20: Analysis of Listed Products by Indicated Product Application

Figure 21: Analysis of Listed Products by Approval

Figure 22: Analysis of Listed Products by Age Eligibility

• tVNS Technologies

• Parasym Ltd.

• BioControl Medical

• ElectroCore Inc.

• LivaNova PLC

• Medtronic Plc.

• Boston Scientific Corporation

• Aleva Neurotherapeutics SA.

• EnteroMedics Inc

  • Tags:
  • Vagus Nerve Stimulator (VNS)
  • Vagus Nerve Stimulator (VNS) Mecha...
  • Vagus Nerve Stimulator (VNS) Compa...
  • Vagus Nerve Stimulator (VNS) Medi...
  • Vagus Nerve Stimulator (VNS) Marke...
  • Vagus Nerve Stimulator (VNS) Indus...

Forward to Friend

Need A Quote